Surmodics (NASDAQ:SRDX) dropped 5.8% after a report about the Federal Trade Commission's review of its planned sale to private equity firm GTCR. The staff of the FTC has some concerns about the $627 ...
On January 17, 2025, the staff at the Federal Trade Commission (FTC) released their first results from the FTC’s Surveillance Pricing market ...
In the days leading up to President Trump’s inauguration, the Biden FTC rushed to initiate major lawsuits and to tie a bow on ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
A staff report released Friday by the FTC suggested partnerships between OpenAI and Microsoft, and Amazon and Anthropic, ...
TechCrunch on MSN7d
FTC says partnerships like Microsoft-OpenAI raise antitrust concernsThe Federal Trade Commission (FTC) said in a staff report issued Friday that there are potential competitive issues in ...
The Federal Trade Commission has issued a warning about phony text messages sent to residents about supposed tolls they owe. The surge in SMS spam has been linked to increased activity by foreign bad ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
The FTC warns that multi-billion-dollar partnerships between Big Tech and AI startups could lead to the monopolization of the AI and cloud computing sectors.
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback